AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30660402 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 47
Study 27834418 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) along with calcium (500 mg) and vitamin D (250 IU) supplementation twice a day for 6 months
Number of subjects: 68
Study 27834418 — intervention group
Group type: COMPARATOR
Intervention: Calcium (500 mg) and vitamin D (250 IU) supplementation twice a day for 6 months
Number of subjects: 68
Study 24872377 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led comorbidity management programme (n=482)
Number of subjects: 970
Study 24872377 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient self-assessment of disease activity (n=488)
Number of subjects: 970
Study 23129180 — intervention group
Group type: EXPERIMENTAL
Intervention: Eldecalcitol (0.75 μg daily)
Number of subjects: 1054
Study 23129180 — intervention group
Group type: COMPARATOR
Intervention: Alfacalcidol (1.0 μg daily)
Number of subjects: 1054
Study 20956385 — intervention group
Group type: EXPERIMENTAL
Intervention: R-appliance
Number of subjects: 30
Study 20956385 — intervention group
Group type: COMPARATOR
Intervention: Twin-block (TB)
Number of subjects: 30
Study 19819762 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Disc Replacement (TDR)
Number of subjects: 152
Study 19819762 — intervention group
Group type: COMPARATOR
Intervention: Posterolateral Fusion (PLF) or Posterior Lumbar Interbody Fusion (PLIF)
Number of subjects: 152
Study 19819762 — intervention group
Group type: COMPARATOR
Intervention: Fusion (PLF or PLIF)
Number of subjects: 152
Study 19819762 — intervention group
Group type: EXPERIMENTAL
Intervention: Both TDR and Fusion
Number of subjects: 152
Study 17477111 — intervention group
Group type: EXPERIMENTAL
Intervention: Drospirenone/estradiol therapy
Number of subjects: 0
Study 15918444 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextran sulfate (60 mg/kg intravenously infused just before cardiopulmonary bypass and 600 mg added to bypass circuit prime)
Number of subjects: 60
Study 15918444 — intervention group
Group type: COMPARATOR
Intervention: Control group (age and body-weight matched)
Number of subjects: 60
Study 12271808 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated treatment
Number of subjects: 341
Study 12271808 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 341
Study 10085522 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood donors
Number of subjects: 968
Study 10085522 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemodialysis patients
Number of subjects: 968
Study 10085522 — intervention group
Group type: EXPERIMENTAL
Intervention: Children infected post transfusion with HCV
Number of subjects: 968
Study 7593897 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocaloric nutrition (14 kcal/kg per day)
Number of subjects: 20
Study 7593897 — intervention group
Group type: COMPARATOR
Intervention: Iso-caloric nutrition (28 kcal/kg per day)
Number of subjects: 20
Study 7593897 — intervention group
Group type: COMPARATOR
Intervention: Hypercaloric nutrition (56 kcal/kg per day)
Number of subjects: 20
Study 2205798 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A (8.7 mumol or 8333 IU) and Vitamin E (46 mumol or 20 mg)
Number of subjects: 15419
Study 2205798 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E alone (control group)
Number of subjects: 15419
Study 2205798 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A (8.7 mumol or 8333 IU)
Number of subjects: 15419
Study 6788458 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone Ro 13-9904, 500 mg
Number of subjects: 54
Study 6788458 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone Ro 13-9904, 250 mg
Number of subjects: 54
Study 6788458 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone Ro 13-9904, 125 mg
Number of subjects: 54
Study 6788458 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone Ro 13-9904, 50 mg
Number of subjects: 54
Study 30796700 — intervention group
Group type: EXPERIMENTAL
Intervention: Panda version of VAS‐100
Number of subjects: 0
Study 30796700 — intervention group
Group type: EXPERIMENTAL
Intervention: Panda version of NRS‐11
Number of subjects: 0
Study 27793514 — intervention group
Group type: EXPERIMENTAL
Intervention: Bridge intervention (n=76)
Number of subjects: 151
Study 27793514 — intervention group
Group type: COMPARATOR
Intervention: Usual mental healthcare (waitlist group, n=75)
Number of subjects: 151
Study 27554534 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabivax-S (1mL IM; five doses)
Number of subjects: 180
Study 27554534 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabivax-S (0.1mL ID; eight doses)
Number of subjects: 180
Study 27554534 — intervention group
Group type: COMPARATOR
Intervention: Purified chick embryo cell vaccine (PCEC, Rabipur®) (1mL IM; five doses)
Number of subjects: 180
Study 27554534 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabivax-S (1mL IM; five doses) and Rabivax-S (0.1mL ID; eight doses)
Number of subjects: 180
Study 27554534 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (Rabivax-S IM, Rabivax-S ID, PCEC IM)
Number of subjects: 180
Study 24631304 — intervention group
Group type: EXPERIMENTAL
Intervention: CET combined with BT
Number of subjects: 45
Study 24631304 — intervention group
Group type: COMPARATOR
Intervention: Usual rehabilitation
Number of subjects: 45
Study 22912458 — intervention group
Group type: COMPARATOR
Intervention: HS-CONT (basal diet)
Number of subjects: 450
Study 22912458 — intervention group
Group type: EXPERIMENTAL
Intervention: HS-MOS (basal diet + 0.5% MOS)
Number of subjects: 450
Study 22912458 — intervention group
Group type: EXPERIMENTAL
Intervention: HS-PM (basal diet + 0.1% PM)
Number of subjects: 450
Study 22912458 — intervention group
Group type: EXPERIMENTAL
Intervention: HS-SYN (basal diet + 0.5% MOS + 0.1% PM)
Number of subjects: 450
Study 22912458 — intervention group
Group type: COMPARATOR
Intervention: CONT (normal ambient temperature)
Number of subjects: 450
Study 19743567 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 12000
Study 19743567 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin (low-molecular-weight heparin)
Number of subjects: 12000
Study 17601186 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) of the subthalamic nucleus (STN)
Number of subjects: 10
Study 17601186 — intervention group
Group type: COMPARATOR
Intervention: Antiparkinsonian medication (presurgery dosage)
Number of subjects: 10
Study 17601186 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched neurologically healthy subjects)
Number of subjects: 10
Study 15040822 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration training (WBV)
Number of subjects: 70
Study 15040822 — intervention group
Group type: COMPARATOR
Intervention: Resistance training (RES)
Number of subjects: 70
Study 15040822 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 70
Study 12899358 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive mood
Number of subjects: 0
Study 12899358 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative mood
Number of subjects: 0
Study 12899358 — intervention group
Group type: COMPARATOR
Intervention: Cue condition (mood manipulation awareness)
Number of subjects: 0
Study 12899358 — intervention group
Group type: EXPERIMENTAL
Intervention: Achievement
Number of subjects: 0
Study 12899358 — intervention group
Group type: COMPARATOR
Intervention: No cue condition
Number of subjects: 0
Study 9842582 — intervention group
Group type: EXPERIMENTAL
Intervention: Hiking sticks
Number of subjects: 11
Study 9842582 — intervention group
Group type: COMPARATOR
Intervention: No hiking sticks (Control)
Number of subjects: 11
Study 8135445 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-release sodium fluoride (25 mg twice daily) with continuous calcium citrate (400 mg calcium twice daily)
Number of subjects: 110
Study 8135445 — intervention group
Group type: COMPARATOR
Intervention: Placebo with continuous calcium citrate (400 mg calcium twice daily)
Number of subjects: 110
Study 2773706 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic field of 400 Gauss
Number of subjects: 0
Study 2773706 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic field of 2000 Gauss
Number of subjects: 0
Study 2773706 — intervention group
Group type: COMPARATOR
Intervention: Placebo (imitation magnet)
Number of subjects: 0
Study 2773706 — intervention group
Group type: COMPARATOR
Intervention: Normal persons (controls)
Number of subjects: 0
Study 2773706 — intervention group
Group type: EXPERIMENTAL
Intervention: Refraction estimation by autorefractometer
Number of subjects: 0
Study 1093389 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent measles-rubella vaccine
Number of subjects: 346
Study 31397969 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin ODT 50 μg
Number of subjects: 532
Study 31397969 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin ODT 25 μg
Number of subjects: 532
Study 31397969 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin ODT 25 μg (females)
Number of subjects: 532
Study 31397969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 532
Study 29582248 — intervention group
Group type: EXPERIMENTAL
Intervention: DS-8500a 50 mg
Number of subjects: 24
Study 29582248 — intervention group
Group type: EXPERIMENTAL
Intervention: DS-8500a 100 mg
Number of subjects: 24
Study 29582248 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 27655643 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin/paclitaxel (carboplatin: AUC5, paclitaxel: 175 mg/m², every 3 weeks for 6 cycles)
Number of subjects: 820
Study 27655643 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin/PLD-pegylated liposomal doxorubicin (carboplatin: AUC5, PLD: 30 mg/m², every 3 weeks for 6 cycles)
Number of subjects: 820
Study 24274836 — intervention group
Group type: EXPERIMENTAL
Intervention: eLearning course for personnel
Number of subjects: 1283
Study 24274836 — intervention group
Group type: COMPARATOR
Intervention: Training-as-usual (control)
Number of subjects: 1283
Study 22415421 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical treatment with 40 mg/day of proton pump inhibitors (PPIs)
Number of subjects: 45
Study 22415421 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment (Nissen fundoplication, NFP)
Number of subjects: 45
Study 20306184 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 1.25 mg (approx. 0.6 mg/kg)
Number of subjects: 0
Study 20306184 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 2.5 mg (approx. 1.2 mg/kg)
Number of subjects: 0
Study 20306184 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2C19 poor metabolizer genotype
Number of subjects: 0
Study 20306184 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety monitoring
Number of subjects: 0
Study 18930097 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccine
Number of subjects: 17622
Study 18930097 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17622
Study 15949393 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibutilide
Number of subjects: 212
Study 15949393 — intervention group
Group type: COMPARATOR
Intervention: Propafenone
Number of subjects: 212
Study 12756694 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified primary health care
Number of subjects: 485
Study 12756694 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 485
Study 10527224 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (titrated until target HR met)
Number of subjects: 40
Study 10527224 — intervention group
Group type: COMPARATOR
Intervention: Esmolol (group 80, target HR < 80 beats/min)
Number of subjects: 40
Study 10527224 — intervention group
Group type: COMPARATOR
Intervention: Esmolol (group 110, target HR < 110 beats/min)
Number of subjects: 40
Study 7496123 — intervention group
Group type: EXPERIMENTAL
Intervention: CS‐3000 Omnix
Number of subjects: 112
Study 7496123 — intervention group
Group type: EXPERIMENTAL
Intervention: AS‐104
Number of subjects: 112
Study 2029014 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (500 mg three times a day) with low sodium diet
Number of subjects: 40
Study 2029014 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (500 mg three times a day) with normal sodium diet
Number of subjects: 40
Study 2029014 — intervention group
Group type: COMPARATOR
Intervention: Placebo with low sodium diet
Number of subjects: 40
Study 2029014 — intervention group
Group type: COMPARATOR
Intervention: Placebo with normal sodium diet
Number of subjects: 40
Study 7024762 — intervention group
Group type: EXPERIMENTAL
Intervention: des‐phe‐mixed‐insulin
Number of subjects: 20
Study 7024762 — intervention group
Group type: COMPARATOR
Intervention: Mixtard (highly purified insulin from pig)
Number of subjects: 20
Study 31667501 — intervention group
Group type: EXPERIMENTAL
Intervention: Learn to Quit app
Number of subjects: 62
Study 31667501 — intervention group
Group type: COMPARATOR
Intervention: QuitGuide app
Number of subjects: 62
Study 29716572 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive emotions
Number of subjects: 663
Study 29716572 — intervention group
Group type: EXPERIMENTAL
Intervention: Any negative emotion reported
Number of subjects: 663
Study 29716572 — intervention group
Group type: EXPERIMENTAL
Intervention: Any positive emotion reported
Number of subjects: 663
Study 27427415 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalised anxiety symptoms
Number of subjects: 2508
Study 24664788 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% L-menthol
Number of subjects: 10
Study 24664788 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% trans-cinnamaldehyde (CA)
Number of subjects: 10
Study 24664788 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of L-menthol and CA
Number of subjects: 10
Study 24664788 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 10
Study 22824349 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole
Number of subjects: 46
Study 22824349 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 46
Study 22824349 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 20044929 — intervention group
Group type: EXPERIMENTAL
Intervention: General practice‐based intervention consisting of screening for fear of partner, feedback to GPs, training for GPs, brief counselling for women, and minimal practice organisational change.
Number of subjects: 500
Study 20044929 — intervention group
Group type: COMPARATOR
Intervention: Basic education and usual care for women (Control group).
Number of subjects: 500
Study 17979967 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral condensation (G1)
Number of subjects: 50
Study 17979967 — intervention group
Group type: EXPERIMENTAL
Intervention: System B (G2)
Number of subjects: 50
Study 17979967 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermafil system (G3)
Number of subjects: 50
Study 15894675 — intervention group
Group type: EXPERIMENTAL
Intervention: ESR1 methylation status
Number of subjects: 196
Study 15894675 — intervention group
Group type: COMPARATOR
Intervention: CDKN2A, PTGS2, or PGR methylation
Number of subjects: 196
Study 12792623 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh tomatoes
Number of subjects: 24
Study 12792623 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed tomato sauce
Number of subjects: 24
Study 12792623 — intervention group
Group type: COMPARATOR
Intervention: Low-lycopene control
Number of subjects: 24
Study 10721870 — intervention group
Group type: EXPERIMENTAL
Intervention: Zotepine (150 or 300 mg/day)
Number of subjects: 158
Study 10721870 — intervention group
Group type: COMPARATOR
Intervention: Chlorpromazine (300 or 600 mg/day)
Number of subjects: 158
Study 10721870 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study 9201668 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 850
Study 9201668 — intervention group
Group type: COMPARATOR
Intervention: Tricyclic antidepressants (TCAs)
Number of subjects: 850
Study 1553769 — intervention group
Group type: EXPERIMENTAL
Intervention: Cololax regimen (oral ingestion of electrolyte polyethylene glycol solution)
Number of subjects: 0
Study 1553769 — intervention group
Group type: COMPARATOR
Intervention: Standard regimen (supplemented by an enema)
Number of subjects: 0
Study 3516293 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-schedule (neutron/photon) irradiation
Number of subjects: 61
Study 3516293 — intervention group
Group type: COMPARATOR
Intervention: Photon therapy
Number of subjects: 61
Study 3516293 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study 31157871 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric residual evaluation
Number of subjects: 0
Study 29203290 — intervention group
Group type: EXPERIMENTAL
Intervention: Conformal radiotherapy with respiratory motion management
Number of subjects: 154
Study 29203290 — intervention group
Group type: COMPARATOR
Intervention: Conformal radiotherapy without respiratory motion management
Number of subjects: 154
Study 26812450 — intervention group
Group type: EXPERIMENTAL
Intervention: RElaxation aNd Exercise for Wellness (RENEW) intervention
Number of subjects: 35
Study 26812450 — intervention group
Group type: EXPERIMENTAL
Intervention: RENEW intervention
Number of subjects: 35
Study 26812450 — intervention group
Group type: COMPARATOR
Intervention: Control group (wait for 12 weeks)
Number of subjects: 35
Study 26011549 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored behavioral pharmacist‐administered and telephone‐based intervention (CITIES)
Number of subjects: 428
Study 26011549 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group not explicitly mentioned)
Number of subjects: 428
Study 23010796 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal welding (TW)
Number of subjects: 120
Study 23010796 — intervention group
Group type: COMPARATOR
Intervention: Classic dissection (CD)
Number of subjects: 120
Study 23010796 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar cautery dissection (BCD)
Number of subjects: 120
Study 20946634 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention condition (specific intervention details not provided)
Number of subjects: 32
Study 20946634 — intervention group
Group type: COMPARATOR
Intervention: Control condition (specific control details not provided)
Number of subjects: 32
Study 17999160 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine infiltration
Number of subjects: 20
Study 17999160 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 20
Study 16614887 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-11 expression in tumor samples
Number of subjects: 109
Study 16614887 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-11 expression in node-positive tumors
Number of subjects: 109
Study 16614887 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-11 expression and prognostic index
Number of subjects: 109
Study 16614887 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-11 and survival analysis
Number of subjects: 109
Study 12749511 — intervention group
Group type: COMPARATOR
Intervention: MIR 500 mg BID
Number of subjects: 217
Study 12749511 — intervention group
Group type: EXPERIMENTAL
Intervention: MXR 1000 mg QD
Number of subjects: 217
Study 12749511 — intervention group
Group type: EXPERIMENTAL
Intervention: MXR 1500 mg QD
Number of subjects: 217
Study 10929921 — intervention group
Group type: EXPERIMENTAL
Intervention: OM‐85 BV
Number of subjects: 200
Study 10929921 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 8836069 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial epicondylectomy
Number of subjects: 0
Study 8836069 — intervention group
Group type: COMPARATOR
Intervention: Ulnar nerve transposition
Number of subjects: 0
Study 1562758 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolrestat
Number of subjects: 0
Study 1562758 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31146957 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular diet plus nutritional supplementation (arginine, glutamine, and fish oil)
Number of subjects: 88
Study 31146957 — intervention group
Group type: COMPARATOR
Intervention: Regular diet
Number of subjects: 88
Study 31207232 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab maintenance therapy
Number of subjects: 375
Study 31207232 — intervention group
Group type: COMPARATOR
Intervention: Guselkumab withdrawal (placebo)
Number of subjects: 375
Study 31207232 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab retreatment after withdrawal
Number of subjects: 375
Study 31207232 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine levels (IL-17A, IL-17F, IL-22)
Number of subjects: 375
Study 31207232 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine levels (IL-23)
Number of subjects: 375
Study 27871802 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic treatment
Number of subjects: 56
Study 27871802 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 26400431 — intervention group
Group type: EXPERIMENTAL
Intervention: Delphinol (maqui berry extract) 162 mg anthocyanins, taken 3 times daily for 4 weeks
Number of subjects: 42
Study 26400431 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 23528153 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflatable obstetric belt (Labor Assister, Baidy M‐520/Curexo, Inc.) during the second stage of labor
Number of subjects: 188
Study 23528153 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 188
Study 23528153 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflatable obstetric belt (Labor Assister)
Number of subjects: 188
Study 21447950 — intervention group
Group type: EXPERIMENTAL
Intervention: CRA with vouchers
Number of subjects: 58
Study 21447950 — intervention group
Group type: COMPARATOR
Intervention: CRA without vouchers
Number of subjects: 58
Study 21447950 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 58
Study 18319362 — intervention group
Group type: EXPERIMENTAL
Intervention: Not eating lunch at school in the sixth grade
Number of subjects: 1498
Study 18319362 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating lunch outside of school
Number of subjects: 1498